# Supernus Pharmaceuticals Inc. (SUPN) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $719M |
| 2024 | $662M |
| 2023 | $608M |
| 2022 | $667M |
| 2021 | $580M |
| 2020 | $520M |
| 2019 | $393M |
| 2018 | $409M |
| 2017 | $302M |
| 2016 | $215M |
| 2015 | $147M |
| 2014 | $93M |
| 2013 | $12M |
| 2012 | $1M |
| 2011 | $803,000 |
| 2010 | $106,000 |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $208M |
| 2025-09-30 | $192M |
| 2025-06-30 | $165M |
| 2025-03-31 | $150M |
| 2024-09-30 | $176M |
| 2024-06-30 | $168M |
| 2024-03-31 | $144M |
| 2023-09-30 | $154M |
| 2023-06-30 | $136M |
| 2023-03-31 | $154M |
| 2022-09-30 | $177M |
| 2022-06-30 | $170M |
| 2022-03-31 | $153M |
| 2021-09-30 | $148M |
| 2021-06-30 | $141M |
| 2021-03-31 | $131M |
| 2020-09-30 | $155M |
| 2020-06-30 | $127M |
| 2020-03-31 | $95M |
| 2019-09-30 | $102M |
| 2019-06-30 | $105M |
| 2019-03-31 | $85M |
| 2018-09-30 | $103M |
| 2018-06-30 | $100M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/SUPN/revenue)